STOCK TITAN

Healthstream 10-Q Filings

HSTM NASDAQ

Every 10-Q that Healthstream (HSTM) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow HSTM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HSTM filings page.

Rhea-AI Summary

HealthStream, Inc. reported solid growth for the quarter ended March 31, 2026. Revenues rose to $81.2 million, up 11% from $73.5 million a year earlier, driven mainly by subscription services of $78.4 million and modest growth in professional services.

Operating income increased to $7.5 million from $4.4 million, while net income improved to $5.9 million, or $0.20 diluted EPS, compared with $4.3 million, or $0.14 diluted EPS, in the prior-year quarter. Adjusted EBITDA reached $20.1 million, up from $16.2 million.

The company ended the quarter with $48.7 million in cash and cash equivalents and $17.8 million in marketable securities, and had no outstanding borrowings under its $50 million revolving credit facility. It returned capital through $7.7 million of share repurchases and a quarterly dividend of $0.035 per share.

Rhea-AI Summary

HealthStream (HSTM) reported Q3 2025 results with revenue of $76.5 million, up 5% year over year, and diluted EPS of $0.20 versus $0.19. Subscription services drove 97% of revenue at $73.9 million, while professional services declined to $2.6 million. Adjusted EBITDA rose to $19.1 million from $17.7 million.

Operating discipline was evident: year-to-date operating cash flow reached $50.1 million, aided by a DSO improvement to 33 days. The company completed its $25.0 million buyback, repurchasing 905,786 shares in 2025, and declared a quarterly dividend of $0.031 per share, payable November 28, 2025 to holders of record on November 17, 2025. Cash and equivalents were $53.5 million with $39.0 million in marketable securities; no borrowings were outstanding on the $50.0 million revolver.

General and administrative costs fell on sublease income, while cost of revenues increased with platform and SaaS investments. As of November 3, 2025, shares outstanding were 29,668,137. Subsequent event: on October 8, 2025, HealthStream acquired Virsys12 for approximately $11.2 million in cash, plus up to $4.0 million contingent on performance, enhancing its provider data management and credentialing suite.